ANTITUMOR EFFICACY OF HUMAN RECOMBINANT INTERLEUKIN-2

被引：0
|
作者：
BUBENIK, J
KIELER, J
INDROVA, M
机构：
[1] CZECHOSLOVAK ACAD SCI, INST MOLEC GENET, CS-11142 PRAGUE 1, CZECHOSLOVAKIA
[2] FIBIGER LAB, DK-2100 COPENHAGEN, DENMARK
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1987年 / 23卷 / 11期
关键词：
D O I：
10.1016/0277-5379(87)90503-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1738 / 1738
页数：1
相关论文
共 50 条
  • [1] THE IMMUNOPHARMACOLOGY, TOXICITY, AND ANTITUMOR EFFICACY OF A NOVEL RECOMBINANT INTERLEUKIN-2
    BRADLEY, EC
    KONRAD, MW
    ISSELL, BF
    [J]. CANCER INVESTIGATION, 1986, 4 (05) : 490 - 490
  • [2] Antitumor Efficacy of Recombinant Human Interleukin-2 Combined with Sorafenib Against Mouse Renal Cell Carcinoma
    Iguchi, Motofumi
    Matsumoto, Mitsunobu
    Hojo, Kanji
    Wada, Toru
    Matsuo, Yoshiyuki
    Arimura, Akinori
    Abe, Kenji
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (05) : 303 - 309
  • [3] AN ANTI-IL-2 ANTIBODY INCREASES SERUM HALFLIFE AND IMPROVES ANTITUMOR EFFICACY OF HUMAN RECOMBINANT INTERLEUKIN-2
    COURTNEY, LP
    PHELPS, JL
    KARAVODIN, LM
    [J]. IMMUNOPHARMACOLOGY, 1994, 28 (03): : 223 - 232
  • [4] Indications and efficacy of human recombinant interleukin-2 (Roncoleukin®) in neonatal infections
    Degtyareva, M. V.
    Ashitkova, N. V.
    Pankratyeva, L. L.
    Soldatova, I. G.
    Volodin, N. N.
    [J]. ADVANCES IN PERINATAL MEDICINE, 2010, : 425 - 428
  • [5] CRYSTALLIZATION OF RECOMBINANT HUMAN INTERLEUKIN-2
    MORIYA, N
    YAMADA, T
    KATO, K
    NISHIMURA, O
    [J]. BIO-TECHNOLOGY, 1986, 4 (10): : 904 - 905
  • [6] CRYSTALLIZATION OF HUMAN RECOMBINANT INTERLEUKIN-2
    SANO, C
    NAGASHIMA, N
    TSUJI, T
    KAWAKITA, T
    FUKUHARA, K
    ISHIKAWA, K
    MITSUI, Y
    IITAKA, Y
    [J]. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 1986, 62 (06): : 209 - 211
  • [7] THE ANTITUMOR EFFICACY OF HUMAN RECOMBINANT INTERLEUKIN-2 - CORRELATION BETWEEN SENSITIVITY OF TUMORS TO THE CYTOLYTIC EFFECT OF LAK CELLS-INVITRO AND THEIR SUSCEPTIBILITY TO INTERLEUKIN-2 IMMUNOTHERAPY INVIVO
    BUBENIK, J
    INDROVA, M
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1987, 24 (03) : 269 - 271
  • [8] ANTITUMOR EFFECTS OF NEW-TYPE RECOMBINANT INTERLEUKIN-2
    FENG, XS
    ZHENG, XJ
    SI, QS
    LIN, YL
    CHANG, Y
    FAN, PF
    YU, JL
    ZHANG, SR
    LIU, XY
    [J]. ACTA PHARMACOLOGICA SINICA, 1992, 13 (05): : 435 - 438
  • [9] MODULATION OF THE EXPRESSION OF INTERLEUKIN-2 RECEPTORS OF HUMAN THYMOCYTES BY RECOMBINANT INTERLEUKIN-2
    REEM, GH
    YEH, NH
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1985, 239 (02) : 455 - 461
  • [10] TUMOR EFFICACY OF POLYETHYLENE GLYCOL-MODIFIED RECOMBINANT HUMAN INTERLEUKIN-2
    ZIMMERMAN, RJ
    AUKERMAN, SL
    LANDRE, P
    GAUNY, S
    BELL, D
    YOUNG, J
    KATRE, N
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (03): : 329 - 330
12345